Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects

Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial

(2016) A Blackman et al.   INTERNATIONAL JOURNAL OF OBESITY

Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers

(2016) Ken Fujioka et al.   Obesity

Adiposopathy and epigenetics: an introduction to obesity as a transgenerational disease

(2015) Harold Bays et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

(2015) Melanie J. Davies et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

(2015) Xavier Pi-Sunyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adiposopathy, “Sick Fat,” Ockham’s Razor, and Resolution of the Obesity Paradox

(2014) Harold Bays   Current Atherosclerosis Reports

Changes in Adipose Tissue Depots and Metabolic Markers Following a 1-Year Diet and Exercise Intervention in Overweight and Obese Patients With Type 2 Diabetes

(2014) Dympna Gallagher et al.   DIABETES CARE

Adipocyte dysfunction, inflammation and metabolic syndrome

(2014) Nora Klöting et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

(2013) J van Can et al.   INTERNATIONAL JOURNAL OF OBESITY

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

(2013) T A Wadden et al.   INTERNATIONAL JOURNAL OF OBESITY

Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

The effect of weight loss on health-related quality of life: systematic review and meta-analysis of randomized trials

(2013) L. M. Warkentin et al.   Obesity Reviews

Adiposopathy, Diabetes Mellitus, and Primary Prevention of Atherosclerotic Coronary Artery Disease: Treating “Sick Fat” Through Improving Fat Function with Antidiabetes Therapies

(2012) Harold E. Bays   AMERICAN JOURNAL OF CARDIOLOGY

The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis

(2009) Daphne P Guh et al.   BMC PUBLIC HEALTH